Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Invesco NASDAQ 100 ETF (QQQM) vs Invesco S&P 500 Momentum ETF (SPMO) Price & Performance

Invesco NASDAQ 100 ETFTrade
Invesco S&P 500 Momentum ETFTrade

Price performance (Past 24H)

Key statistics

Invesco NASDAQ 100 ETF vs Invesco S&P 500 Momentum ETF — how do they compare? Invesco NASDAQ 100 ETF trades at $308.67 (market cap $113.40B), while Invesco S&P 500 Momentum ETF trades at $150.95 (market cap $23.48B). The key difference: Invesco NASDAQ 100 ETF is far larger — about 4.8× Invesco S&P 500 Momentum ETF's market cap, and Invesco NASDAQ 100 ETF is trading nearer its 52-week high, Invesco S&P 500 Momentum ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Invesco NASDAQ 100 ETF for 54 Days and Invesco S&P 500 Momentum ETF for 54 Days on average.

QQQMSPMO
Market Cap
$113.40B$23.48B
Volume
2,866,2361,876,152
Sector
Broad Market / FactorBroad Market / Factor
52-Week High
$312.76$161.66
52-Week Low
$229.87$107.84
Typical Hold Time
54 Days54 Days

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Invesco NASDAQ 100 ETF

QQQM trades at $308.42, down 1.15% on the day, while maintaining a bullish technical outlook with strong moving average support. The ETF's lower 0.15% expense ratio compared to QQQ's 0.18% provides a cost advantage, though trading spreads can impact returns. Recent institutional buying includes QRG Capital Management increasing its position by 207.5% during Q2 2026, signaling confidence in the Nasdaq-100 exposure.

The ETF offers pure Nasdaq-100 exposure with competitive fees, though investors should be aware of concentration risk in technology stocks and potential tax implications of distributions. Technical indicators suggest near-term support at $305 with resistance at $311, while institutional accumulation supports the bullish case for long-term growth investors.

Invesco S&P 500 Momentum ETF

SPMO trades at $153.00, showing minimal daily movement with a 0.01% gain. The ETF maintains a bullish technical outlook with strong moving average signals, though oscillators suggest neutral momentum. Recent portfolio reconstitution added 54 stocks including Apple and Merck, while removing Nvidia. Institutional interest remains strong with Envestnet Asset Management increasing its stake by 9.5% in Q2 2026.

The momentum-focused ETF offers concentrated exposure to S&P 500's fastest-rising stocks, historically outperforming the broader index. Key risks include sector concentration in technology and higher volatility. Analyst sentiment remains positive given the fund's structural momentum advantage and institutional accumulation trends.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

QQQM
77% Buy23% Sell
Avg holding period · 54 Days
SPMO
49% Buy51% Sell
Avg holding period · 54 Days

Top news

Latest headlines on both assets

About Invesco NASDAQ 100 ETF

QQQM is an ETF designed to track the performance of the NASDAQ-100 Index. It provides exposure to the 100 largest non-financial companies listed on the NASDAQ. Positioned as a lower-cost and more long-term-investor-friendly alternative to its peer QQQ, QQQM offers the same fundamental market exposure but typically has a lower share price and is structured to appeal to investors focused on accumulation rather than active trading.

Read more on QQQM →

About Invesco S&P 500 Momentum ETF

SPMO is designed to track the investment results of the S&P 500 Momentum Index. This index measures the performance of stocks in the S&P 500 that exhibit the highest momentum, or the greatest price appreciation, over the trailing 12 months, while excluding the most recent month. By investing in these high-momentum stocks, SPMO seeks to capitalize on the historical trend that stocks with strong recent performance tend to continue that performance in the near term, offering a systematic approach to factor investing within the large-cap U.S. equity market.

Read more on SPMO →